GlassScriptPhysician profile
Tammy E Hostetler
NPI 1881258416
$6,950.94
in general payments reported to CMS, 2019-2025
16 companies · $1,349 in 2025
The $1,349 reported for 2025 was more than what 86% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,442 · 2022: $1,575 · 2023: $1,162 · 2024: $1,423 · 2025: $1,349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,922 · Education: $12.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,922.12 |
| Education | $12.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $1,553.78 | 2021-2025 | Lybalvi, Aristada, Aristada Initio |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,402.36 | 2021-2025 | Caplyta |
| Abbvie INC. | $639.03 | 2022-2024 | |
| E.R. Squibb & Sons, L.L.C. | $517.73 | 2024-2025 | Cobenfy |
| Teva Pharmaceuticals USA, INC. | $477.57 | 2021-2025 | Uzedy, Austedo Xr |
| Neurocrine Biosciences, INC. | $470.46 | 2021-2025 | Ingrezza |
| Otsuka America Pharmaceutical, INC. | $440.01 | 2021-2024 | Abilify Maintena, Abilify Asimtufii |
| Janssen Pharmaceuticals, INC | $389.83 | 2022-2025 | Invega Sustenna, Invega Trinza |
| Corium, LLC | $355.08 | 2022-2025 | Azstarys |
| Axsome Therapeutics, INC. | $277.12 | 2023-2025 | Auvelity |
| Indivior INC. | $153.89 | 2021-2023 | Sublocade |
| Ironshore Pharmaceuticals INC. | $113.85 | 2024 | |
| Sunovion Pharmaceuticals INC. | $54.44 | 2022 | |
| Lundbeck LLC | $50.22 | 2022-2024 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $33.38 | 2022-2023 | Trintellix |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $22.19 | 2023 | Qelbree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tammy Hostetler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.